Mark Jedrychowski, PhD

Senior Director and Head of Proteomics at Matchpoint Therapeutics

Mark Jedrychowski, PhD has extensive work experience in the field of proteomics and biomedical research. Mark currently serves as the Senior Director and Head of Proteomics at Matchpoint Therapeutics since May 2021. Prior to this, they held various roles at Harvard Medical School, including Lead Scientist and Director of the Thermo Fisher Center for Multiplexed Proteomics from June 2019 to August 2022, Senior Staff Scientist from July 2016 to May 2019, and Post Doctoral Fellow from June 2009 to June 2016. Mark also worked as a Research Associate at Harvard Medical School from January 2000 to August 2003.

Mark Jedrychowski, PhD completed their education in a chronological order. First, they attended Kingswood Oxford, although the specific dates, degree, and field of study are unknown. Afterwards, they studied at Tufts University from 1995 to 2000, earning both a Bachelor of Science and Master of Science degrees in Chemistry. Finally, they pursued their doctoral degree at Boston University School of Medicine from 2003 to 2009, specializing in Biochemistry.

Location

Boston, United States

Links


Org chart


Teams


Offices

This person is not in any offices


Matchpoint Therapeutics

Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry libraryevolution. Matchpoint has an emerging pipeline of novel covalent medicines, initially focused on immunology.


Employees

11-50

Links